NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
NephroDI Therapeutics has raised $2.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in June 2024.
NephroDI Therapeutics is headquartered in Philadelphia, United States.
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
NephroDI Therapeutics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"NephroDI Therapeutics — Funding & Investors." VCBacked, June 11, 2024, https://www.vcbacked.co/company/nephrodi-therapeutics. Accessed August 14, 2026.
VCBacked. (2024). NephroDI Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/nephrodi-therapeutics
{{cite web |title=NephroDI Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/nephrodi-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated